BioSpace News Archive

Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients

Ascletis Pharma Inc. (HKEX code: 1672) announces today the first clinical study using Ganovo®(danoprevir) to treat naive and experienced COVID-19 patients was published in medRxiv.

March 24, 2020
·
2 min read
Biotech Bay

ZAP Surgical Announces Comprehensive Webinar Series Focused on Advancing Stereotactic Radiosurgery for Treating Brain Tumors

ZAP Surgical Systems, Inc. today announced a program offering web-based educational talks focused on stereotactic radiosurgery (SRS) and its related applications

March 24, 2020
·
3 min read
BioCapital

SPI Pharma Expands Mannogem® Mannitol Product Portfolio to support the development, manufacture and administration of oral dosage forms.

SPI Pharma has announced an expansion of its line of Mannogem Mannitol products for use in multiple patient-friendly oral dosage forms to now include: Mannogem XL Opal, Mannogem XL Ruby, Mannogem Emerald, and Mannogem Onyx.

March 24, 2020
·
3 min read
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations

eTheRNA Immunotherapies nv announced that a consortium has been formed with North American and European partners to develop a novel mRNA vaccine against CoV-2 and preclinical development has started.

March 24, 2020
·
6 min read
Business

IDEAYA Biosciences, Inc. Reports Fourth Quarter 2019 Financial Results and Provides Business Update

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics, provided a business update and announced financial results for the fourth quarter ended December 31, 2019.

March 24, 2020
·
11 min read
Business

Cricket Health Expands Collaboration with Cigna

Innovative collaboration will improve kidney disease care and lower costs for Cigna customers

March 24, 2020
·
2 min read
Business

Karuna Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results and Provides General Business Update

Met primary endpoint in Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia and demonstrated favorable safety profile with no significant weight gain, somnolence or extrapyramidal side effects relative to placebo

March 24, 2020
·
12 min read
Biotech Beach

Viriom donates Elpida to Chinese and Russian governments for experimental use against COVID-19;

Viriom Inc announces the company’s activities to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Elpida (elsulfavirine) and Viriom’s experimental flu medicines AV5080, AV5124 and AV5126 to determine their efficacy in the treatment of COVID-19.

March 24, 2020
·
3 min read
Policy

Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS™ Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS)

Helius Medical Technologies, Inc., announced that its Canadian Class II license amendment application for the treatment of gait deficit in patients with mild and moderate symptoms from multiple sclerosis has received marketing authorization from Health Canada.

March 24, 2020
·
4 min read
Business

Akcea Therapeutics Announces Appointment of Dr. Damien McDevitt as CEO

Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceuticals, Inc., announced that its board of directors has appointed Damien McDevitt, Ph.D. as Chief Executive Officer, effective immediately.

March 24, 2020
·
4 min read